Rytelo Injection, Powder, Lyophilized, For Solution
Product Images NDC 82959-112

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rytelo (NDC 82959-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Geron Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rytelo 01)

Chemical structure diagram of imetelstat sodium, the active ingredient in RYTELO injection, powder, lyophilized for solution. The structure depicts the molecular arrangement of atoms and bonds characteristic of this compound.*

FDA Label Image

Principal Display Panel (47 mg Vial Label)

Label for RYTELO (imetelstat) injection powder, lyophilized, for solution, 47 mg per vial. The label indicates it is for intravenous use after reconstitution and dilution, stored refrigerated at 2°C to 8°C (36°F to 46°F). Manufactured by Patheon Italia, S.p.A and labeled as a product of South Korea. Includes NDC 82959-112-01, lot number, expiration, and barcode information.*

FDA Label Image

Principal Display Panel (47 mg Vial Carton)

Carton label for RYTELO (imetelstat) injection, 47 mg per vial, lyophilized powder for intravenous solution. The label includes dosage strength, manufacturer Geron Corporation, and storage instructions to refrigerate at 2°C to 8°C. It indicates a single-dose vial with disposal instructions for unused portions and notes the product is for intravenous infusion after reconstitution and dilution.*

FDA Label Image

Principal Display Panel (188 mg Vial Label)

Label for RYTELO (imetelstat) injection, showing the 188 mg per vial strength. It is a single-dose vial for intravenous infusion after reconstitution and dilution. The label includes storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F) and not to freeze, along with manufacturer information listing Catalent Indiana, LLC and product origin from South Korea. The National Drug Code (NDC) number 82959-111-01 is also displayed.*

FDA Label Image

Principal Display Panel (188 mg Vial Carton)

Carton packaging label for RYTELO (imetelstat) injection, 188 mg per vial, a lyophilized powder for intravenous solution. The label indicates single-dose vial with instructions for reconstitution and dilution. Manufactured for Geron Corporation, Foster City, CA, and by Catalent Indiana, LLC, Bloomington, IN. The product is from South Korea. Storage instructions require refrigeration at 2°C to 8°C and no preservatives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.